These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 210295

  • 21. Suppression of growth of guinea pig line-10 hepatocarcinoma. II. Effect of passive transfer of xenogeneic and syngeneic antibodies and normal lymphoid cells.
    Minden P, Brunda MJ, Ferguson HR.
    J Immunol; 1978 Nov; 121(5):1933-8. PubMed ID: 712072
    [Abstract] [Full Text] [Related]

  • 22. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH, van de Plas MM, Steerenberg PA, Kruizinga W, Ruitenberg EJ.
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [Abstract] [Full Text] [Related]

  • 23. Recombinant interleukin-12 and interleukin-18 antitumor therapy in a guinea-pig hepatoma cell implant model.
    Shiratori I, Suzuki Y, Oshiumi H, Begum NA, Ebihara T, Matsumoto M, Hazeki K, Kodama K, Kashiwazaki Y, Seya T.
    Cancer Sci; 2007 Dec; 98(12):1936-42. PubMed ID: 17888032
    [Abstract] [Full Text] [Related]

  • 24. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
    Ren W, Strube R, Zhang X, Chen SY, Huang XF.
    Cancer Res; 2004 Sep 15; 64(18):6645-51. PubMed ID: 15374979
    [Abstract] [Full Text] [Related]

  • 25. Tumor regression caused by endotoxins and mycobacterial fractions.
    Ribi EE, Granger DL, Milner KC, Strain SM.
    J Natl Cancer Inst; 1975 Nov 15; 55(5):1253-7. PubMed ID: 173865
    [Abstract] [Full Text] [Related]

  • 26. A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: implication for immunotherapy of human hepatocellular carcinoma.
    Atarashi Y, Yasumura S, Nambu S, Yoshio Y, Murakami J, Takahara T, Higuchi K, Watanabe A, Miyata K, Kato M.
    Hepatology; 1998 Jul 15; 28(1):57-67. PubMed ID: 9657097
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct 15; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 29. Shared antigens between bacteria and guinea pig line 10 hepatocarcinoma cells.
    Minden P, Sharpton TR, McClatchy JK.
    Cancer Res; 1976 May 15; 36(5):1680-5. PubMed ID: 57823
    [Abstract] [Full Text] [Related]

  • 30. Enhanced macrophage tumoricidal activity and tumor suppression or regression caused by heat-killed Candida albicans.
    Weinberg JB, Hibbs JB.
    J Natl Cancer Inst; 1979 Nov 15; 63(5):1273-8. PubMed ID: 388016
    [Abstract] [Full Text] [Related]

  • 31. Immunotherapy with nonviable microbial components.
    Ribi E, Milner KC, Granger DL, Kelly MT, Yamamoto K, Brehmer W, Parker R, Smith RF, Strain SM.
    Ann N Y Acad Sci; 1976 Nov 15; 277(00):228-38. PubMed ID: 187099
    [Abstract] [Full Text] [Related]

  • 32. Marked stimulation of lymphocyte-mediated attack on tumor cells by target-directed liposomes containing immune RNA.
    Magee WE, Cronenberger JH, Thor DE.
    Cancer Res; 1978 Apr 15; 38(4):1173-6. PubMed ID: 205346
    [Abstract] [Full Text] [Related]

  • 33. Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma.
    Sun K, Wang L, Zhang Y.
    Cell Mol Immunol; 2006 Jun 15; 3(3):197-203. PubMed ID: 16893500
    [Abstract] [Full Text] [Related]

  • 34. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
    Zhang W, Liu J, Wu Y, Xiao F, Wang Y, Wang R, Yang H, Wang G, Yang J, Deng H, Li J, Wen Y, Wei Y.
    Biochem Biophys Res Commun; 2008 Nov 07; 376(1):10-4. PubMed ID: 18725206
    [Abstract] [Full Text] [Related]

  • 35. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM, Riggs CW, Hanna MG.
    Cancer Res; 1977 Aug 07; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract] [Full Text] [Related]

  • 36. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T, Tokunaga T, Murohashi T.
    J Natl Cancer Inst; 1977 Mar 07; 58(3):803-8. PubMed ID: 320348
    [Abstract] [Full Text] [Related]

  • 37. Suppression of tumor growth in strain 2 guinea pigs by xenogeneic antitumor antibody.
    Smith HG, Meltzer MS, Leonard EJ.
    J Natl Cancer Inst; 1976 Oct 07; 57(4):809-13. PubMed ID: 187778
    [Abstract] [Full Text] [Related]

  • 38. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.
    Churchill WH, Zbar B, Belli JA, David JR.
    J Natl Cancer Inst; 1972 Feb 07; 48(2):541-9. PubMed ID: 4119886
    [No Abstract] [Full Text] [Related]

  • 39. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Feb 07; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

  • 40. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.
    Fatourou EM, Koskinas JS.
    Expert Rev Anticancer Ther; 2009 Oct 07; 9(10):1499-510. PubMed ID: 19828011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.